← Open Payments lookup

CAROLE JOLLEY: Open Payments

NPI 1932982006 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,346 in 389 payments from 22 companies in 2025. Trend: 2023 $1,165 · 2024 $5,034 · 2025 $6,346

Food & beverage: $6,245Education: $101
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.71$1,349
ABBVIE INC.104$935
Teva Pharmaceuticals USA, Inc.23$584
Alkermes, Inc.22$423
Otsuka America Pharmaceutical, Inc.27$326
E.R. Squibb & Sons, L.L.C.15$320
Janssen Pharmaceuticals, Inc18$307
Axsome Therapeutics, Inc.13$296
Vanda Pharmaceuticals Inc.14$293
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$262

Products named: INGREZZA, VRAYLAR, REXULTI, AUSTEDO XR, ARISTADA, COBENFY, Auvelity, FANAPT.

Industry payments across NC — which companies pay providers there.